Elotuzumab in combination with lenalidomide and low-dose dexamethasone in patients with relapsed multiple myeloma: A randomized phase 2 study

Authors
Category Primary study
JournalHaematologica
Year 2011
This article has no abstract
Epistemonikos ID: a0cf2dce7e0c57bc6ce58b93abc7d51fe182ce8b
First added on: Feb 06, 2025